Treatment for UTI in Patients with Kidney Disease

Antibiotic Selection and Treatment Duration

The American College of Cardiology is not applicable here, however, the European Urology guidelines recommend using fluoroquinolones (ciprofloxacin or levofloxacin) as first-line therapy for patients with kidney disease and UTI, with interval extension based on creatinine clearance, or trimethoprim-sulfamethoxazole if local resistance is <20%, both requiring 7-14 days of treatment depending on UTI complexity 1
For complicated UTI/Pyelonephritis, the European Urology guidelines recommend a treatment duration of 7-14 days 3, 4, 5
Short-duration therapy (5-7 days) achieves similar clinical success as long-duration therapy (10-14 days), even in patients with bacteremia 4, 5
For men, the European Urology guidelines recommend using a 14-day duration when prostatitis cannot be excluded 3
For patients with diabetes mellitus, the guidelines recommend treating for 14 days as diabetes defines all UTIs as complicated 1

For patients with creatinine clearance 30-50 mL/min, the guidelines recommend 500 mg of ciprofloxacin every 12 hours (no dose reduction needed) 1
For patients with creatinine clearance <30 mL/min, the guidelines recommend extending the interval to every 24 hours or using an alternative agent 1
For hemodialysis patients, the guidelines recommend administering antibiotics after hemodialysis sessions to prevent drug removal during dialysis 1, 2

For antibiotic selection in polycystic kidney disease, the guidelines recommend using lipid-soluble antibiotics (TMP-SMX or fluoroquinolones) as they penetrate cysts better 1, 2
The treatment duration for confirmed cyst infection is 4-6 weeks 6, 1
The diagnostic criteria for kidney cyst infection include fever with acute abdominal/flank pain, C-reactive protein ≥50 mg/L or WBC >11 × 10⁹/L, and obtaining blood cultures if suspected 6

Before initiating therapy, the guidelines recommend obtaining urine culture and susceptibility testing 3, 2
The guidelines also recommend obtaining blood cultures if upper UTI or cyst infection is suspected 6
The guidelines advise against treating asymptomatic bacteriuria 6, 2

The guidelines recommend avoiding nitrofurantoin in patients with creatinine clearance <30 mL/min due to insufficient efficacy and high risk of peripheral neuritis 1, 2
The guidelines also recommend avoiding aminoglycosides except for single-dose therapy in simple cystitis due to nephrotoxicity risk 1, 2

For carbapenem-resistant Enterobacterales (CRE), the guidelines recommend using ceftazidime-avibactam 2.5 g IV every 8 hours with renal dose adjustment, meropenem-vaborbactam 4 g IV every 8 hours with renal dosing, or imipenem-cilastatin-relebactam 1.25 g IV every 6 hours with renal dosing 1, 2